Skip to content

Medical-device intelligence

GGN: Plasma, Coagulation Control

FDA product code GGN: Plasma, Coagulation Control. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
GGN
FDA device name
Plasma, Coagulation Control
Device class
2
Regulation number
864.5425
Medical specialty
Hematology
Review panel
HE

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore hematology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

99 clearance records and 16 recall records in the covered releases, across 44 source company names and 1 product codes. Dated history runs from Aug 22, 1977 to Jul 1, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202601
May 202600
June 202600
July 202601
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
GGN · Plasma, Coagulation Control9916

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

115 matching records
Device / recordCompany in FDA recordSourceSource date
5-PLASMA Bivalirudin Control, Model Number 5D-44905Z-2896-2026 · GGNAniara Diagnostica LLCRecallAug 5, 2026FDA classification date
directCHECK ACT-LR whole blood quality control, level 2 Model/Catalog Number: DCGLR-2Z-2460-2026 · GGNAccriva Diagnostics, Inc.RecallJun 16, 2026FDA classification date
BIOPHEN UFH Control PlasmaZ-1743-2022 · GGNAniara Diagnostica LLCRecallSep 15, 2022FDA record creation date
STA SYSTEM CONROL N + P (ref. 00678)Z-0738-2020 · GGNDiagnostica Stago, Inc.RecallDec 23, 2019FDA classification date
BIOPHEN UFH Control C2, REF 223901Z-1188-2019 · GGNAniara Diagnostica LLCRecallApr 17, 2019FDA record creation date
BIOPHEN UFH Control C1, REF 224101Z-1189-2019 · GGNAniara Diagnostica LLCRecallApr 17, 2019FDA record creation date
BIOPHEN LMWH Control C4, REF 224201Z-1190-2019 · GGNAniara Diagnostica LLCRecallApr 17, 2019FDA record creation date
VALIDATE D-Dimer Calibration Verification / Linearity Test KitK170864 · GGNMaine Standards Company, LLC510(k)Jun 21, 2017FDA decision date
VALIDATE Heparin Calibration Verification/Linearity Test KitK163498 · GGNMaine Standards Company, LLC510(k)Mar 16, 2017FDA decision date
George King Coumadin PlasmaK161316 · GGNGeorge King Bio-Medical, Inc.510(k)Feb 23, 2017FDA decision date
VALIDATE® D-Dimer Calibration Verification/ Linearity Test KitK162705 · GGNMaine Standards Company, LLC510(k)Jan 5, 2017FDA decision date
VALIDATE D-Dimer Calibration Verification/Linearity Test KitK152961 · GGNMaine Standards Company, LLC510(k)Jun 3, 2016FDA decision date
ROTROL P Control for ROTEM delta Thromboelastometry System, For In Vitro Diagnostic Use Only. Quality control material for monitoring accuracy a…Z-1090-2016 · GGNTEM Systems IncRecallMar 9, 2016FDA record creation date
VisuCon-F Low Fibrinogen Control PlasmaK150144 · GGNAffinity Biologicals, Inc.510(k)Mar 6, 2016FDA decision date
POOL NORMK142132 · GGNDiagnostics Stago S.A.S.510(k)Dec 12, 2014FDA decision date
HEMOSIL D-DIMER HS 500 CONTROLK133582 · GGNInstrumentation Laboratory510(k)Aug 15, 2014FDA decision date
HemosIL Normal Control 1 UNASSAYED Part Number: 0020003120Z-0514-2014 · GGNInstrumentation Laboratory Co.RecallDec 16, 2013FDA classification date
HemosIL Low Abnormal Control 2 UNASSAYED Part Number: 0020003220Z-0515-2014 · GGNInstrumentation Laboratory Co.RecallDec 16, 2013FDA classification date
HemosIL High Abnormal Control 3 UNASSAYED Part Number: 0020003320Z-0516-2014 · GGNInstrumentation Laboratory Co.RecallDec 16, 2013FDA classification date
DIRECTCHECK CONTROL FOR HEMOCHRON JR. MICROCOAGULATION SYSTEMS ACT-LR CUVETTE DIRECTCHECK CONTROLS FOR HEMOCHRON JR. MICK120977 · GGNInternational Technidyne Corp.510(k)Jul 3, 2013FDA decision date
I-STAT PT CONTROL LEVIEL 1 I-STAT PT CONTROL LEVEL 2K120900 · GGNCliniqa Corporation510(k)May 31, 2013FDA decision date
STA- COAG CONTROL (N+ABN) PLUSK120014 · GGNDiagnostica Stago, Inc.510(k)Mar 14, 2013FDA decision date
STA - System Control N + P Product Usage: The STA -System Control N+P kit provides a normal plasma and an abnormal plasma intended for use as tw…Z-1044-2012 · GGNDiagnostica Stago, Inc.RecallFeb 16, 2012FDA classification date
HEMOSIL LA POSITIVE CONTROL & HEMOSIL LA NEGATIVE CONTROLK113211 · GGNInstrumentation Laboratory CO510(k)Jan 4, 2012FDA decision date
VISUCON-F FROZEN COAG SCREEN N, VISUCON-F FROZEN COAG SCREEN ABNK110432 · GGNAffinity Biologicals, Inc.510(k)Oct 20, 2011FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗